Foresight Group International AG Appoints Tim Neely as New Managing Director in Japan

Tim Neely joins Foresight to lead growth of pharmacovigilance and regulatory services for clients of Foresight Japan

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Tim Neely, New Managing Director of Foresight Japan

With Tim’s proven track record with assignments in Japan, we believe that his understanding of the local culture and business practices will support Foresight in our efforts to grow our business within the Life Science and Pharmaceutical industry.

Zug, Switzerland (PRWEB) July 05, 2012

Based in Tokyo, industry veteran Tim Neely has joined Foresight Group International AG as Managing Director, of Foresight Japan. With his strong foundation in International Business Development, Tim will lead and manage the Japan office.

“With Tim’s proven track record of achieving success with his previous assignments in Japan, we believe that his deep understanding of the local culture, market, and business practices will support Foresight in our efforts to grow our business within the Life Science and Pharmaceutical industry," said Brian Dinardo, Partner, Foresight.

Neely has 20 years of management experience serving the life science and pharmaceutical industry in Japan. He previously held the position as Senior Business Development Executive at IBM Japan as well as Sales Director for Wipro Technologies. As a top sales leader, Tim led a team of Business Development Managers to provide technology services to high tech, pharmaceutical, and medical customers. He has been responsible for achieving revenue growth and developing diverse portfolios with top tier multinational pharmaceutical companies.

Neely holds a Bachelor of Arts degree in Political Science from the University of Nebraska as well as a degree in Japanese language from Keio University, Japan.

About Foresight
Foresight Group International AG is a global management and technology services company focused exclusively on clinical and post-marketing drug safety and surveillance. We offer a full range of services with experienced pharmacovigilance experts in every major PV market in the world: North America, Europe, India and Japan. Our best-in-class partnership with Oracle for the implementation of Oracle Argus Safety Suite coupled with our deep expertise in drug safety lets Foresight offer clients the most comprehensive pharmacovigilance services and solutions available in industry today. All of our services and solutions are delivered with precise, timely and cost-effective execution to help our clients achieve and sustain regulatory compliance and manage risk.

To learn more about Foresight, visit http://www.foresightgroup.com.


Contact